Previous 10 | Next 10 |
home / stock / mir:cc / mir:cc news
HALIFAX, NS / ACCESSWIRE / September 27, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) provides an update on its progress to achieve regulatory approval in Canada and the USA for its infectious disease rapid tests. Currently the Company has two submissions filed with Health Canada and one subm...
Canadian Investment Regulatory Organization Trade Resumption - MIR Canada NewsWire VANCOUVER, BC , Aug. 31, 2023 /CNW/ - Trading resumes in: Company: MedMira Inc. TSX-Venture Symbol: MIR All Issues: Yes Resumption (ET): 9:30 AM 9/1/2023 ...
HALIFAX, NS / ACCESSWIRE / August 30, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) has completed, with its Transfer Agent, the process and has received confirmation by the TSX.v as follows: "Further to the resumption of trading of the shares of MedMira Inc., (the "Company"), the Exchange adv...
TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC , Aug. 29, 2023 /CNW/ - TSX VENTURE COMPANIES TACTICAL RESOURCES CORP. ("RARE ") BULLETIN TYPE: New Listing-Shares BULLETIN DATE: August 29, 202...
Canadian Investment Regulatory Organization Trading Halt - MIR Canada NewsWire VANCOUVER, BC , Aug. 29, 2023 /CNW/ - The following issues have been halted by CIRO Company: MedMira Inc. TSX-Venture Symbol: MIR All Issues: Yes Reason: Failure to...
HALIFAX, NS / ACCESSWIRE / June 29, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended April 30, 2023. Corporate Update Summary During the third financial quarter of 2023, MedMira continued its focus on its regulatory and clinical trial wo...
HALIFAX, NS / ACCESSWIRE / April 3, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2023. Corporate Update Summary During the second financial quarter of 2023, MedMira continued its focus on its COVID-19 and Sexually Transmi...
HALIFAX, NS / ACCESSWIRE / February 20, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the singing of a multinational distribution agreement with Maternova, Inc. , Rhode Island, USA. Maternova is a US-based distribution company specialising in maternal and infant he...
Maternova, Inc. , accelerating advances in maternal and infant health through innovative, accessible solutions, and MedMira Inc. (TSXV: MIR), a developer and manufacturer of rapid diagnostics, today announced that the companies have entered into a multinational distribution agreement. Under...
HALIFAX, NS / ACCESSWIRE / January 11, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of the CE mark for its VYRA™ CoV2Flu Antigen Test (VYRA™ CoV2Flu), the fastest combination antigen test available to detect SARS-CoV-2, Flu A and Flu B. The Company received...
News, Short Squeeze, Breakout and More Instantly...
HALIFAX, NS / ACCESSWIRE / July 2, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended April 30, 2024. Corporate update In Q3 FY2024, MedMira focused on the launch of MedMira's latest US FDA approved Reveal ® G4 Rapid HIV 1/2 antibody...
HALIFAX, NS / ACCESSWIRE / April 30, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the position of Vice President of Business Development. Ms. Bell brings over 20 years of Business Development a...
HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2024. Corporate update During Q2 FY2024, MedMira received the US FDA 510(k) clearance for the HIV-2 claim on the Reveal ® G4 Rapid HIV...